C J L M Meijer
Overview
Explore the profile of C J L M Meijer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
4469
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donken R, Hoes J, Knol M, Ogilvie G, Dobson S, King A, et al.
BMC Infect Dis
. 2020 Jul;
20(1):482.
PMID: 32640998
Background: Persistent high-risk human papillomavirus (HPV) infection is endorsed by the World Health Organization as an intermediate endpoint for evaluating HPV vaccine effectiveness/efficacy. There are different approaches to estimate the...
2.
Vink F, Lissenberg-Witte B, Meijer C, Berkhof J, van Kemenade F, Siebers A, et al.
Clin Microbiol Infect
. 2020 Mar;
27(1):125.e1-125.e6.
PMID: 32222459
Objectives: The aim was to evaluate the cross-sectional and long-term triage performance of FAM19A4/miR124-2 methylation analysis in human papillomavirus (HPV)-based cervical screening. Methods: We conducted a post hoc analysis within...
3.
Leeman A, Jenkins D, Marra E, van Zummeren M, Pirog E, van de Sandt M, et al.
Br J Dermatol
. 2019 Jul;
182(4):1026-1033.
PMID: 31302935
Objectives: Because current guidelines recognise high-grade anal squamous intraepithelial lesions (HSILs) and low-grade SILs (LSILs), and recommend treatment of all HSILs although not all progress to cancer, this study aims...
4.
Polman N, Snijders P, Kenter G, Berkhof J, Meijer C
Prev Med
. 2018 Dec;
119:108-117.
PMID: 30594536
Based on scientific data showing that HPV testing provides better protection against cervical precancer and cancer than cytology, in 2011 the Dutch Health Council advised the Minister of Welfare, Health...
5.
Donken R, King A, Bogaards J, Woestenberg P, Meijer C, de Melker H
J Infect Dis
. 2018 Feb;
217(10):1579-1589.
PMID: 29409034
Background: Monitoring vaccine effectiveness (VE) in vaccination programs is of importance for assessing the impact of immunization. This study aimed to estimate the VE of the bivalent human papillomavirus (HPV)...
6.
Polman N, Ostrbenk A, Xu L, Snijders P, Meijer C, Poljak M, et al.
J Clin Microbiol
. 2017 Oct;
55(12):3544-3551.
PMID: 29021152
Human papillomavirus (HPV) testing is increasingly being incorporated into cervical cancer screening. The Validation of HPV Genotyping Tests (VALGENT) is a framework designed to evaluate the clinical performance of various...
7.
Uijterwaal M, van Zummeren M, Kocken M, Luttmer R, Berkhof J, Witte B, et al.
Gynecol Oncol
. 2016 Jul;
143(1):135-142.
PMID: 27430395
Introduction: Recent studies have shown that CADM1/MAL-methylation testing detects high-grade CIN lesions with a high short-term progression risk for cervical cancer. Women treated for CIN2/3 are at risk of post-treatment...
8.
Geraets D, Cuschieri K, de Koning M, van Doorn L, Snijders P, Meijer C, et al.
J Clin Microbiol
. 2016 Jun;
54(7):1927.
PMID: 27343293
No abstract available.
9.
Louwers J, Zaal A, Kocken M, Berkhof J, Papagiannakis E, Snijders P, et al.
Gynecol Oncol
. 2015 Oct;
139(3):452-7.
PMID: 26475960
OBJECTIVE. A previous study has shown that Dynamic Spectral Imaging (DSI) colposcopy increases the sensitivity of the colposcopic examination in women referred with abnormal cytology. In this study we have...
10.
Arbyn M, Snijders P, Meijer C, Berkhof J, Cuschieri K, Kocjan B, et al.
Clin Microbiol Infect
. 2015 May;
21(9):817-26.
PMID: 25936581
Several countries are in the process of switching to high-risk human papillomavirus (hrHPV) testing for cervical cancer screening. Given the multitude of available tests, validated assays which assure high-quality screening...